This current meta-analysis was performed to explore the correlation of ZFAS1 expression with clinical outcome of cancer patients, and further determine whether ZFAS1 could serve as an effective biomarker for metastasis and prognosis. This evidence concerns the gene ZFAS1 and cancer.